Cardiopulmonary Exercise Testing Is an Accurate Tool for the Diagnosis of Pulmonary Arterial Hypertension in Scleroderma Related Diseases

The early diagnosis of pulmonary arterial hypertension (PAH) is a major determinant of prognosis in patients affected by connective tissue diseases (CTDs) complicated by PAH. In the present paper we investigated the diagnostic accuracy of cardiopulmonary exercise testing (CPET) in this specific sett...

Full description

Bibliographic Details
Main Authors: Mattia Bellan, Ailia Giubertoni, Cristina Piccinino, Mariachiara Buffa, Debora Cromi, Daniele Sola, Roberta Pedrazzoli, Ileana Gagliardi, Elisa Calzaducca, Erika Zecca, Filippo Patrucco, Giuseppe Patti, Pier Paolo Sainaghi, Mario Pirisi
Format: Article
Language:English
Published: MDPI AG 2021-04-01
Series:Pharmaceuticals
Subjects:
Online Access:https://www.mdpi.com/1424-8247/14/4/342
_version_ 1797538366900666368
author Mattia Bellan
Ailia Giubertoni
Cristina Piccinino
Mariachiara Buffa
Debora Cromi
Daniele Sola
Roberta Pedrazzoli
Ileana Gagliardi
Elisa Calzaducca
Erika Zecca
Filippo Patrucco
Giuseppe Patti
Pier Paolo Sainaghi
Mario Pirisi
author_facet Mattia Bellan
Ailia Giubertoni
Cristina Piccinino
Mariachiara Buffa
Debora Cromi
Daniele Sola
Roberta Pedrazzoli
Ileana Gagliardi
Elisa Calzaducca
Erika Zecca
Filippo Patrucco
Giuseppe Patti
Pier Paolo Sainaghi
Mario Pirisi
author_sort Mattia Bellan
collection DOAJ
description The early diagnosis of pulmonary arterial hypertension (PAH) is a major determinant of prognosis in patients affected by connective tissue diseases (CTDs) complicated by PAH. In the present paper we investigated the diagnostic accuracy of cardiopulmonary exercise testing (CPET) in this specific setting. We recorded clinical and laboratory data of 131 patients who underwent a CPET at a pulmonary hypertension clinic. Out of them, 112 (85.5%) had a diagnosis of CTDs; 8 (6.1%) received a diagnosis of CTDs-PAH and 11 (8.4%) were affected PH of different etiology. Among CPET parameters the following parameters showed the best diagnostic performance for PAH: peak volume of oxygen uptake (VO<sub>2</sub>; AUC: 0.845, CI95% 0.767–0.904), ratio between ventilation and volume of exhaled carbon dioxide (VE/VCO<sub>2</sub> slope; AUC: 0.888, CI95%: 0.817–0.938) and end-tidal partial pressures (PetCO<sub>2</sub>; AUC: 0.792, CI95%: 0.709–0.861). These parameters were comparable among CTDs-PAH and PH of different etiology. The diagnostic performance was even improved by creating a composite score which included all the three parameters identified. In conclusion, CPET is a very promising tool for the stratification of risk of PAH among CTDs patients; the use of composite measures may improve diagnostic performance.
first_indexed 2024-03-10T12:29:33Z
format Article
id doaj.art-01d06c8ce19a4681925a3d5fdd7f1f92
institution Directory Open Access Journal
issn 1424-8247
language English
last_indexed 2024-03-10T12:29:33Z
publishDate 2021-04-01
publisher MDPI AG
record_format Article
series Pharmaceuticals
spelling doaj.art-01d06c8ce19a4681925a3d5fdd7f1f922023-11-21T14:42:55ZengMDPI AGPharmaceuticals1424-82472021-04-0114434210.3390/ph14040342Cardiopulmonary Exercise Testing Is an Accurate Tool for the Diagnosis of Pulmonary Arterial Hypertension in Scleroderma Related DiseasesMattia Bellan0Ailia Giubertoni1Cristina Piccinino2Mariachiara Buffa3Debora Cromi4Daniele Sola5Roberta Pedrazzoli6Ileana Gagliardi7Elisa Calzaducca8Erika Zecca9Filippo Patrucco10Giuseppe Patti11Pier Paolo Sainaghi12Mario Pirisi13Department of Translational Medicine, Università del Piemonte Orientale UPO, 28100 Novara, ItalyDepartment of Translational Medicine, Università del Piemonte Orientale UPO, 28100 Novara, Italy“AOU Maggiore della Carità” Hospital, 28100 Novara, ItalyDepartment of Translational Medicine, Università del Piemonte Orientale UPO, 28100 Novara, ItalyDepartment of Translational Medicine, Università del Piemonte Orientale UPO, 28100 Novara, Italy“AOU Maggiore della Carità” Hospital, 28100 Novara, Italy“AOU Maggiore della Carità” Hospital, 28100 Novara, ItalyDepartment of Translational Medicine, Università del Piemonte Orientale UPO, 28100 Novara, ItalyDepartment of Translational Medicine, Università del Piemonte Orientale UPO, 28100 Novara, ItalyDepartment of Translational Medicine, Università del Piemonte Orientale UPO, 28100 Novara, ItalyDepartment of Translational Medicine, Università del Piemonte Orientale UPO, 28100 Novara, ItalyDepartment of Translational Medicine, Università del Piemonte Orientale UPO, 28100 Novara, ItalyDepartment of Translational Medicine, Università del Piemonte Orientale UPO, 28100 Novara, ItalyDepartment of Translational Medicine, Università del Piemonte Orientale UPO, 28100 Novara, ItalyThe early diagnosis of pulmonary arterial hypertension (PAH) is a major determinant of prognosis in patients affected by connective tissue diseases (CTDs) complicated by PAH. In the present paper we investigated the diagnostic accuracy of cardiopulmonary exercise testing (CPET) in this specific setting. We recorded clinical and laboratory data of 131 patients who underwent a CPET at a pulmonary hypertension clinic. Out of them, 112 (85.5%) had a diagnosis of CTDs; 8 (6.1%) received a diagnosis of CTDs-PAH and 11 (8.4%) were affected PH of different etiology. Among CPET parameters the following parameters showed the best diagnostic performance for PAH: peak volume of oxygen uptake (VO<sub>2</sub>; AUC: 0.845, CI95% 0.767–0.904), ratio between ventilation and volume of exhaled carbon dioxide (VE/VCO<sub>2</sub> slope; AUC: 0.888, CI95%: 0.817–0.938) and end-tidal partial pressures (PetCO<sub>2</sub>; AUC: 0.792, CI95%: 0.709–0.861). These parameters were comparable among CTDs-PAH and PH of different etiology. The diagnostic performance was even improved by creating a composite score which included all the three parameters identified. In conclusion, CPET is a very promising tool for the stratification of risk of PAH among CTDs patients; the use of composite measures may improve diagnostic performance.https://www.mdpi.com/1424-8247/14/4/342pulmonary arterial hypertensionsystemic sclerosissclerodermacardiopulmonary exercise testing
spellingShingle Mattia Bellan
Ailia Giubertoni
Cristina Piccinino
Mariachiara Buffa
Debora Cromi
Daniele Sola
Roberta Pedrazzoli
Ileana Gagliardi
Elisa Calzaducca
Erika Zecca
Filippo Patrucco
Giuseppe Patti
Pier Paolo Sainaghi
Mario Pirisi
Cardiopulmonary Exercise Testing Is an Accurate Tool for the Diagnosis of Pulmonary Arterial Hypertension in Scleroderma Related Diseases
Pharmaceuticals
pulmonary arterial hypertension
systemic sclerosis
scleroderma
cardiopulmonary exercise testing
title Cardiopulmonary Exercise Testing Is an Accurate Tool for the Diagnosis of Pulmonary Arterial Hypertension in Scleroderma Related Diseases
title_full Cardiopulmonary Exercise Testing Is an Accurate Tool for the Diagnosis of Pulmonary Arterial Hypertension in Scleroderma Related Diseases
title_fullStr Cardiopulmonary Exercise Testing Is an Accurate Tool for the Diagnosis of Pulmonary Arterial Hypertension in Scleroderma Related Diseases
title_full_unstemmed Cardiopulmonary Exercise Testing Is an Accurate Tool for the Diagnosis of Pulmonary Arterial Hypertension in Scleroderma Related Diseases
title_short Cardiopulmonary Exercise Testing Is an Accurate Tool for the Diagnosis of Pulmonary Arterial Hypertension in Scleroderma Related Diseases
title_sort cardiopulmonary exercise testing is an accurate tool for the diagnosis of pulmonary arterial hypertension in scleroderma related diseases
topic pulmonary arterial hypertension
systemic sclerosis
scleroderma
cardiopulmonary exercise testing
url https://www.mdpi.com/1424-8247/14/4/342
work_keys_str_mv AT mattiabellan cardiopulmonaryexercisetestingisanaccuratetoolforthediagnosisofpulmonaryarterialhypertensioninsclerodermarelateddiseases
AT ailiagiubertoni cardiopulmonaryexercisetestingisanaccuratetoolforthediagnosisofpulmonaryarterialhypertensioninsclerodermarelateddiseases
AT cristinapiccinino cardiopulmonaryexercisetestingisanaccuratetoolforthediagnosisofpulmonaryarterialhypertensioninsclerodermarelateddiseases
AT mariachiarabuffa cardiopulmonaryexercisetestingisanaccuratetoolforthediagnosisofpulmonaryarterialhypertensioninsclerodermarelateddiseases
AT deboracromi cardiopulmonaryexercisetestingisanaccuratetoolforthediagnosisofpulmonaryarterialhypertensioninsclerodermarelateddiseases
AT danielesola cardiopulmonaryexercisetestingisanaccuratetoolforthediagnosisofpulmonaryarterialhypertensioninsclerodermarelateddiseases
AT robertapedrazzoli cardiopulmonaryexercisetestingisanaccuratetoolforthediagnosisofpulmonaryarterialhypertensioninsclerodermarelateddiseases
AT ileanagagliardi cardiopulmonaryexercisetestingisanaccuratetoolforthediagnosisofpulmonaryarterialhypertensioninsclerodermarelateddiseases
AT elisacalzaducca cardiopulmonaryexercisetestingisanaccuratetoolforthediagnosisofpulmonaryarterialhypertensioninsclerodermarelateddiseases
AT erikazecca cardiopulmonaryexercisetestingisanaccuratetoolforthediagnosisofpulmonaryarterialhypertensioninsclerodermarelateddiseases
AT filippopatrucco cardiopulmonaryexercisetestingisanaccuratetoolforthediagnosisofpulmonaryarterialhypertensioninsclerodermarelateddiseases
AT giuseppepatti cardiopulmonaryexercisetestingisanaccuratetoolforthediagnosisofpulmonaryarterialhypertensioninsclerodermarelateddiseases
AT pierpaolosainaghi cardiopulmonaryexercisetestingisanaccuratetoolforthediagnosisofpulmonaryarterialhypertensioninsclerodermarelateddiseases
AT mariopirisi cardiopulmonaryexercisetestingisanaccuratetoolforthediagnosisofpulmonaryarterialhypertensioninsclerodermarelateddiseases